|
20 Jul 2007 |
HMP approves labelling update of Acomplia(R) in Europe and confirms the positive benefit-risk profile of the product except in patients suffering from ongoing major depression
|
|
19 Jul 2007 |
Neurochem receives approvable letter for eprodisate (KIACTA(TM)) for treatment of AA amyloidosis
|
|
19 Jul 2007 |
U.S. FDA and European EMEA Accept Registration Applications for Ceftobiprole, a Novel Anti-MRSA Broad-Spectrum Cephalosporin
|
|
19 Jul 2007 |
Mpex Pharmaceuticals Initiates Multi-dose Clinical Trial in the U.S. with MP-376 in Patients with Cystic Fibrosis
|
|
19 Jul 2007 |
New Drug Application for Investigational HIV Treatment TMC125 Submitted to U.S. Food and Drug Administration
|
|
19 Jul 2007 |
Merck Transfers Abbott Rights for Niaspan Outside the U.S.
|
|
18 Jul 2007 |
Cortex to Resume Clinical Trial with AMPAKINE® CX717 in Alzheimer-PET Scan Study after FDA Approves Protocol with Higher Doses of Drug
|
|
18 Jul 2007 |
Metabasis Therapeutics Announces CS-917 Phase 2b Clinical Trial Results and Reports on Status of Pradefovir
|
|
18 Jul 2007 |
RSV Drug Starts Phase Ia Clinical Trials
|
|
18 Jul 2007 |
Penwest Enters Into Collaboration Agreement With Edison Pharmaceuticals
|
|
18 Jul 2007 |
DURECT Reports Positive Results from POSIDUR(TM) Phase IIb Hernia Trial, Triggering $8 million Milestone Payment from Nycomed
|
|
18 Jul 2007 |
FDA Approves Extina(R) for the Treatment of Seborrheic Dermatitis
|
|
18 Jul 2007 |
Sirtris Pharmaceuticals Presents Results of Studies of SIRT1 Activators at 6th Annual Metabolic Diseases Drug Discovery and Development World Summit
|
|
18 Jul 2007 |
Theratechnologies Regains Japanese Rights for TH9507
|
|
18 Jul 2007 |
ABILIFY(R) (aripiprazole) Supplemental New Drug Application Receives Priority Review by U.S. Food And Drug Administration for Adjunctive Treatment in Adults With Major Depressive Disorder
|
|
18 Jul 2007 |
Salix Pharmaceuticals Announces Submission Of Balsalazide Tablet New Drug Application
|
|
18 Jul 2007 |
PPD Completes First-in-Human Trial for Novel Statin
|
|
17 Jul 2007 |
Amira Pharmaceuticals Starts First Clinical Trial of Lead Compound With Potential in Asthma and Cardiovascular Disease
|
|
17 Jul 2007 |
Roche And BioCryst Advance BCX-4208/R3421 Into Phase II Psoriasis Trial
|
|
17 Jul 2007 |
NicOx receives Euro 5 million milestone from Merck & Co., Inc.
|
|
17 Jul 2007 |
Prometic and Laboratorios Dermatologicos Darier S.A. enter into agreement for PBI-1308 with respect to dermatological disorders
|
|
17 Jul 2007 |
ACADIA Pharmaceuticals Earns Milestone on Advancement of Glaucoma Drug Candidate
|
|
17 Jul 2007 |
Millennium Initiates Phase III Trial to Determine the Optimal VELCADE(R) (Bortezomib) for Injection Based Therapy in Newly Diagnosed Multiple Myeloma Patients
|
|
17 Jul 2007 |
Hollis-Eden Pharmaceuticals Reports Initial Results in Phase I Clinical Trial of HE3286 as New Type II Diabetes Treatment
|
|
17 Jul 2007 |
Can-Fite Reports Results of a Phase IIb Clinical Study in Rheumatoid Arthritis with CF101, an A3 Adenosine Receptor Agonist. The Results Support Further Clinical Development of CF101
|
